GE HealthCare Technologie... (GEHCV)
NASDAQ: GEHCV
· Real-Time Price · USD
56.00
-2.38 (-4.08%)
At close: Jan 04, 2023, 6:00 AM
GE HealthCare Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 19.97B | 19.8B | 19.85B | 19.34B | 19.18B | 19.28B | 14.46B | 14.23B | 9.53B | 4.59B |
Cost of Revenue | 11.51B | 11.33B | 11.45B | 11.44B | 11.42B | 11.59B | 8.7B | 8.55B | 5.73B | 2.73B |
Gross Profit | 8.46B | 8.48B | 8.4B | 7.9B | 7.77B | 7.7B | 5.76B | 5.68B | 3.79B | 1.86B |
Operating Income | 2.71B | 2.67B | 2.66B | 2.47B | 2.48B | 2.63B | 2.02B | 2.19B | 1.51B | 749M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6M | 6M | 6M |
Pretax Income | 2.79B | 2.76B | 2.7B | 2.44B | 2.33B | 2.47B | 1.83B | 2.02B | 1.47B | 755M |
Net Income | 2.04B | 1.99B | 2.31B | 2.49B | 2.73B | 2.87B | 1.98B | 1.85B | 1.14B | 576M |
Selling & General & Admin | 4.24B | 4.28B | 4.24B | 4.17B | 4.2B | 4.01B | 3.02B | 2.86B | 1.79B | 910M |
Research & Development | 1.38B | 1.41B | 1.39B | 1.26B | 1.22B | 1.16B | 839M | 766M | 496M | 225M |
Other Expenses | n/a | 1M | 1M | 1M | 1M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 5.63B | 5.69B | 5.62B | 5.43B | 5.42B | 5.17B | 3.86B | 3.62B | 2.29B | 1.14B |
Interest Expense | 446M | 464M | 492M | 536M | 542M | 470M | 332M | 201M | 65M | 6M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.14B | 17.02B | 17.07B | 16.87B | 16.83B | 16.76B | 12.56B | 12.17B | 8.02B | 3.86B |
Income Tax Expense | -366M | -396M | -542M | -698M | -693M | -399M | -149M | 167M | 330M | 179M |
Shares Outstanding (Basic) | 457M | 457M | 456M | 457M | 457M | 455M | 455M | 454M | 422.9M | n/a |
Shares Outstanding (Diluted) | 458M | 459M | 459M | 459M | 459M | 458M | 458M | 457M | 422.9M | n/a |
EPS (Basic) | 2.63 | 2.51 | 3.23 | 5.47 | 6.00 | 6.40 | 4.45 | 2.90 | 1.34 | n/a |
EPS (Diluted) | 2.63 | 2.50 | 3.20 | 5.42 | 5.95 | 6.36 | 4.43 | 2.89 | 1.34 | n/a |
EBITDA | 3B | 2.96B | 2.95B | 2.47B | 2.35B | 2.67B | 2.05B | 2.38B | 1.82B | 903M |
EBIT | -1.46B | -1.46B | -682M | 1.34B | 2.03B | 2.8B | 2.03B | 2.22B | 1.54B | 761M |
Depreciation & Amortization | 122.92M | 122.92M | 122.88M | 82.5K | -122.92M | 34.08M | 34.12M | 188M | 311M | 154M |